Anatara to feature on ABC’s Landline
Very excited that the story of Anatara Lifesciences and our anti-infective product, Detach™ will feature on ABC’s Landline program this Sunday, March 19 at 12pm. Make sure you tune into see how we plan...
View ArticleABC Landline Story “How pineapples could protect piglets from infection”
“Diarrhoea can be deadly in pig farming. Scour, as it’s called in the industry, kills tens of thousands of piglets every year. It’s traditionally been treated with antibiotics, but a Queensland...
View ArticleAnatara 4C Quarterly Financial Report
Anatara Lifesciences is pleased to release its Appendix 4C Quarterly Financial Report for the quarter ended 31 March 2017. Please click here to view the ASX announcement.
View ArticleUpdate to Anatara 4C Quarterly Report
Anatara Lifesciences wishes to update the description of item 1.8 in the Company’s Appendix 4C for the period ending 31 March 2017, which was released to market this morning. Please click here to view...
View ArticleInvestor Update and R&D Tax Rebate
Anatara Lifesciences is pleased to provide investors with an update on recent progress. Please click here to view the ASX announcement.
View ArticleNEW Wilsons Research & Valuation Report
NEW Wilsons Research & Valuation Report Wilsons Equity Research has released its latest research and valuation report on Anatara Lifesciences (ANR). The report maintained a BUY rating and a price...
View ArticleAnatara 4C Quarterly Financial Report
Anatara Lifesciences is pleased to release its Appendix 4C Quarterly Financial Report for the quarter ended 30 June 2017. Please click here to view the ASX announcement.
View ArticlePAC Partners initiates analyst coverage on Anatara Lifesciences
This month PAC Partners initiated analyst coverage on Anatara Lifesciences. PAC has initiated coverage with a Buy rating and price target of $1.36/share. To download the full report, please click here.
View ArticleAnatara Lifesciences Trading Halt
The securities of Anatara Lifesciences have been placed in Trading Halt Session State at the request of the Company, pending a release of an announcement by the Company. Please click here to view the...
View ArticleAnatara and Zoetis to negotiate terms of Detach® Commercial Agreement
Anatara Lifesciences is pleased to announce that global animal health company, Zoetis Inc. (‘Zoetis’) has exercised its option to negotiate a commercial agreement for the worldwide development,...
View ArticlePreliminary Final Report
Anatara Lifesciences today released its Appendix 4E and financial report for the year ending 30th June 2017. Please click here to view the ASX announcement.
View ArticleAnatara Extends Pork CRC Options
Anatara Lifesciences has today undertaken to extend by 12 months the expiry date of 250,000 Options which Anatara issued to the Pork Cooperative Research Centre (CRC) in 2015. Please click here to view...
View ArticleAnnual Report to Shareholders
Anatara is pleased to release its 2017 Annual Report to its shareholders. Please click here for the ASX announcement.
View ArticleAppendix 4G and Corporate Governance Statement
Anatara Lifesciences is pleased to release its Appendix 4G and Corporate Governance Statement for shareholders. Please click here for the ASX announcement.
View ArticleDr Tracey Mynott to speak at the TRI Science Business Inspiration Series
Anatara Lifesciences CSO, Dr Tracey Mynott, will speak at the first session of the Science Business Inspiration Series next week. SESSION 1 – THE WHOLE JOURNEY: FROM IDEA TO REALITY For more...
View ArticleNotice of General Meeting & Proxy Form
Anatara Lifesciences is pleased to release its Notice of General Meeting and Proxy Form for shareholders. Please click here for the ASX announcement.
View ArticleAnatara Investor Presentation
Anatara Lifesciences is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO & Chairman, Dr Mel Bridges and...
View ArticleAppendix 4C Quarterly Financial Report
Anatara Lifesciences is pleased to release its Appendix 4C Quarterly Financial Report for the quarter ended 30 September 2017. Please click here to view the ASX announcement.
View ArticleChairman’s Address and AGM Presentation
Anatara Lifesciences is pleased to release the presentation and Chairman’s address provided to shareholders at the Annual General Meeting held today, 13th November 2017. Please click here to view the...
View ArticleAnnual General Meeting 2017 Results
Anatara Lifesciences is pleased to announce the following results from the Annual General Meeting held on 13th November 2017. At today’s Annual General Meeting all Resolutions put to Shareholders were...
View Article
